Avail Vapor LLC lost its challenge to the Food and Drug Administration’s denial of its premarket tobacco product application for new flavored electronic cigarettes, after the Fourth Circuit sided with the federal agency Monday.
Avail failed to disprove the FDA’s conclusion that its products pose a serious risk to youth without enough offsetting benefits to adults, the US Court of Appeals for the Fourth Circuit.
The holding is the latest victory for the FDA as it fights the negative effects flavored cigarettes have on young smokers. The D.C. Circuit ruled in July that the FDA’s denial of a premarket tobacco ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
